The European Medicines Agency’s (EMA) 2016 annual report, published earlier this month, focuses on the Agency’s key achievements in the areas of medicine evaluation, support to research and development of new and innovative treatments and the safety monitoring of medicines in real life. According to the report, the Agency recommended a marketing authorisation for 81 medicines for human use, including 27 new active substances. Also highlighted was EMA’s contribution to addressing public health challenges such as antimicrobial resistance, a key issue on which EuCheMS published some recommendations.

Source: http://www.ema.europa.eu/